Long-term irreversible trastuzumab-induced cardiotoxicity for metastatic breast cancer in a patient without cardiac risk factors
Author:
Publisher
Oxford University Press (OUP)
Subject
Cell Biology,Developmental Biology,Embryology,Anatomy
Link
http://academic.oup.com/omcr/article-pdf/2017/7/omx038/18171747/omx038.pdf
Reference13 articles.
1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;N Engl J Med,2001
2. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;N Engl J Med,2005
3. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity;J Clin Oncol,2005
4. Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience;J Clin Oncol,2006
5. Cardiac dysfunction associated with trastuzumab;Expert Opin Drug Saf,2006
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond;Biomolecules;2024-02-07
2. Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats;Life Sciences;2023-09
3. The mechanism and treatment of targeted anti-tumour drugs induced cardiotoxicity;International Immunopharmacology;2023-04
4. Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review;International Journal of Medical Toxicology and Forensic Medicine;2022-03-01
5. Risk Profiling of Cancer Treatment-Related Cardiovascular Disorders in Breast Cancer Patients Who Received Adjuvant Chemotherapy With Trastuzumab;Circulation Reports;2020-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3